| |
FREEDOMSCOPE ADVISORY BOARD MEMBERS 2008/2009
- James Sapirstein, CEO Tobira Therapeutics, Princeton NJ
- David V. Kerns, Jr., Franklin and Mary Olin Distinguished Professor
Of Electrical and Computer Engineering; Founding Provost, Olin College
Professor of Technology Entrepreneurship, Babson College, Boston, MA
- Ralph Makar, CEO, Bioject Medical Device, Inc., Portland OR
- Michael Kramer, CEO, Deslodge Oxygen Tallahassee FL
- Roy Kulick, MD, MBA, Regulatory consultant,
Former Clinical Research Director with Ethicon/Johnson and Johnson,
Specialty: hearing disability and medical devices
- Charles Ranson, Esq, Washington DC, Lobbyist
Military and defense contractor applications
- Cindy Holmes, President, Association of Fundraising Professionals
Previous Chief Operating Officer, Florida Dental Association
- Gus Ray, Director of Commercialization, Florida State University
- Andrew Forman, MBA, Equity Research Analyst, 12 years experience on Wall Street, ranked #1 BioPhamaceutical Analyst in May 2006 Wall Street Journal and Forbes.
- Johnny Moore, JD Columbia University, MBA University of Chicago; Citibank Associate, Investment Banking, Healthcare Division
- Mark Moore, MD, Founder, Tallahassee Florida,
The Advisory Board is organized as a voluntary group, whose function is to advise Freedomscope Corporation during the early phase of organization, capitalization and commercial production of its flagship product, the Bluetooth® wireless stethoscope. The Advisory Board is organized as a separate entity and not a part of the Freedomscope Corporation. |
